IL17A and neoplasm: Furthermore, despite the low number of these T cells, histological analysis of representative sensitive and resistant tumors confirmed detectable levels of IL-17A protein throughout the tumor with increased relative abundance in DOX sensitive tumors (Figures 5C, D).